Literature DB >> 28065854

The mechanism of NLRP3 inflammasome initiation: Trimerization but not dimerization of the NLRP3 pyrin domain induces robust activation of IL-1β.

Petra Sušjan1, Samo Roškar2, Iva Hafner-Bratkovič3.   

Abstract

NLRP3 inflammasome is a multiprotein platform for the activation of caspase-1. Despite the increasing number of reports linking NLRP3 inflammasome to a variety of diseases, the mechanism behind the NLRP3 activation remains elusive, especially in terms of the early stages which are critical to the NLRP3 inflammasome assembly. In the present study we aimed to determine the minimal oligomerization state required for the NLRP3 inflammasome activation. For this purpose, NLRP3 pyrin domain (NLRP3PYD) was fused to various dimerization and trimerization domains. The constructs were expressed under the inducible promoter in mouse macrophages lacking endogenous NLRP3. Dimerization of the NLRP3PYD either in parallel or in antiparallel orientation was insufficient for the inflammasome activation. Trimerization of the NLRP3PYD with the foldon domain, however, induced pyroptosis and robust IL-1β maturation, which was caspase-1 dependent. Interestingly, foldon-induced constitutive activation is resistant to inhibition with NLRP3-specific inhibitor MCC950 and does not lead to ASC speck formation. Although we cannot exclude that wild-type NLRP3 forms higher oligomer species similar to NLRP1 or NLRC4, our results clearly demonstrate that efficient IL-1β response can be achieved by the induced trimerization of the NLRP3PYD domain.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammasome; NLRP3; Oligomerization; Pyrin

Mesh:

Substances:

Year:  2017        PMID: 28065854     DOI: 10.1016/j.bbrc.2017.01.008

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  The Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation.

Authors:  Yang Zhou; Zhizi Tong; Songhong Jiang; Wenyan Zheng; Jianjun Zhao; Xiangmei Zhou
Journal:  Cells       Date:  2020-05-14       Impact factor: 6.600

2.  NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway.

Authors:  Iva Hafner-Bratkovič; Petra Sušjan; Duško Lainšček; Ana Tapia-Abellán; Kosta Cerović; Lucija Kadunc; Diego Angosto-Bazarra; Pablo Pelegrin; Roman Jerala
Journal:  Nat Commun       Date:  2018-12-05       Impact factor: 14.919

Review 3.  Interplay Between NLRP3 Inflammasome and Autophagy.

Authors:  Monika Biasizzo; Nataša Kopitar-Jerala
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

Review 4.  Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes.

Authors:  Meenakshi Sharma; Eva de Alba
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

Review 5.  Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review).

Authors:  Xiaolu Zhang; Wenyun Zeng; Yue Zhang; Qun Yu; Miao Zeng; Jiali Gan; Wenlan Zhang; Xijuan Jiang; Huhu Li
Journal:  Int J Mol Med       Date:  2022-04-08       Impact factor: 5.314

6.  The Inflammasome Activity of NLRP3 Is Independent of NEK7 in HEK293 Cells Co-Expressing ASC.

Authors:  Dominik Alexander Machtens; Ian Philipp Bresch; Jan Eberhage; Thomas Frank Reubold; Susanne Eschenburg
Journal:  Int J Mol Sci       Date:  2022-09-07       Impact factor: 6.208

7.  Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction.

Authors:  Yi Zhang; Xuehua Lv; Zizhong Hu; Xiaojian Ye; Xinhua Zheng; Yuzhi Ding; Ping Xie; Qinghuai Liu
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

8.  Differential Effect of Extracellular Acidic Environment on IL-1β Released from Human and Mouse Phagocytes.

Authors:  Petra Sušjan; Mojca Benčina; Iva Hafner-Bratkovič
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.